XML 24 R6.htm IDEA: XBRL DOCUMENT v3.24.1
CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY (DEFICIT) - USD ($)
Standstill Warrants
Additional paid-in capital
Iliad
Standstill Warrants
Additional paid-in capital
Irving
Standstill Warrants
Iliad
Standstill Warrants
Irving
Royalty Interest Global Amendment Warrants
Additional paid-in capital
Streeterville
Royalty Interest Global Amendment Warrants
Additional paid-in capital
Iliad
Royalty Interest Global Amendment Warrants
Additional paid-in capital
Irving
Royalty Interest Global Amendment Warrants
Streeterville
Royalty Interest Global Amendment Warrants
Iliad
Royalty Interest Global Amendment Warrants
Irving
At The Market Offering
Common Stock
Common stock - voting
At The Market Offering
Additional paid-in capital
At The Market Offering
Pipe financing
Preferred Stock
Series G convertible preferred stock
Pipe financing
Additional paid-in capital
Pipe financing
Preferred Stock
Series G convertible preferred stock
Preferred Stock
Series H convertible preferred stock
Streeterville
Preferred Stock
Series H convertible preferred stock
Irving
Preferred Stock
Series I convertible preferred stock
Irving
Preferred Stock
Series I convertible preferred stock
Common Stock
Series G convertible preferred stock
Common Stock
Series H convertible preferred stock
Irving
Common Stock
Series I convertible preferred stock
Irving
Common Stock
Common stock - voting
Streeterville
Common Stock
Common stock - voting
Iliad
Common Stock
Common stock - voting
Irving
Common Stock
Common stock - voting
Common Stock
Common stock - non-voting
Additional paid-in capital
Streeterville
Additional paid-in capital
Iliad
Additional paid-in capital
Irving
Additional paid-in capital
Noncontrolling Interest
Accumulated deficit
Accumulated other comprehensive loss
Streeterville
Iliad
Irving
Total
Beginning Balance at Dec. 31, 2021                                                                 $ 231,105,000 $ 242,000 $ (219,494,000)         $ 11,853,000
Beginning Balance (in shares) at Dec. 31, 2021                                                       644,700 9                      
Increase (decrease) in Stockholders' Equity (Deficit)                                                                                
Issuance of common stock                       $ 20,462,000 $ 20,462,000                                                      
Issuance of common stock (In shares)                     923,164                                                          
Shares issued in exchange of notes payable and accrued interest                                                           $ 5,056,000 $ 6,207,000           $ 5,056,000 $ 6,207,000    
Shares issued in exchange of notes payable and accrued interest (in shares)                                                 310,196 235,461                            
Common stock issued to other third party for services                                                                 23,000             23,000
Common stock issued to other third party for services (in shares)                                                       20,151                        
Stock-based compensation                                                                 3,218,000             3,218,000
Shares issued to Synworld for services                                                                 800,000             800,000
Shares issued to Synworld for services (in shares)                                                       45,896                        
Common stock issued upon exercise of restricted stock units                                                                 100,000             100,000
Common stock issued upon exercise of restricted stock units (in shares)                                                       2,516                        
Net loss                                                                   (941,000) (47,454,000)         (48,395,000)
Translation Gain (Loss)                                                                       $ (680,000)       (680,000)
Ending Balance at Dec. 31, 2022                                                                 266,971,000 (699,000) (266,948,000) (680,000)       (1,356,000)
Ending Balance (in shares) at Dec. 31, 2022                                                       2,182,084 9                      
Increase (decrease) in Stockholders' Equity (Deficit)                                                                                
Issuance of common stock                     $ 6,000 $ 32,094,000 $ 32,100,000                                     $ 2,022,000             $ 2,022,000  
Issuance of common stock (In shares)                     54,283,779                               2,058,651                          
Shares issued in exchange of notes payable and accrued interest                             $ 611,000 $ 611,000                   $ 1,000       $ 1,730,000 $ 2,063,000 $ 2,201,000         $ 1,730,000 $ 2,064,000 $ 2,201,000  
Shares issued in exchange of notes payable and accrued interest (in shares)                           137       73 32 118           6,245,005                            
Common stock issued to other third party for services                                                                 171,000             171,000
Common stock issued to other third party for services (in shares)                                                       18,869                        
Additional investment from non-controlling interests                                                                   1,233,000           1,233,000
Warrants issued in Underwriter settlement agreement $ 535,000 $ 1,934,000 $ 535,000 $ 1,934,000 $ 59,000 $ 54,000 $ 61,000 $ 59,000 $ 54,000 $ 61,000         $ 1,236,000 $ 1,236,000                                                
Stock-based compensation                                                                 2,103,000             2,103,000
Common stock issued upon exercise of restricted stock units                                                                 9,000             9,000
Common stock issued upon exercise of restricted stock units (in shares)                                                       13,149                        
Common shares issued to conversion of Series Preferred Stock                                           $ 375,000 $ 1,600,000                                  
Common shares issued from conversion of Series Preferred Stock (in shares)                                 (15) (73) (32) (62)       2,985,362 3,650,000                              
RSUs issued (in shares)                                                       1,349                        
Net loss                                                                   (601,000) (41,300,000)         (41,901,000)
Translation Gain (Loss)                                                                   3,000   28,000       31,000
Ending Balance at Dec. 31, 2023                                                       $ 7,000         $ 313,854,000 $ (64,000) $ (308,248,000) $ (652,000)       $ 4,897,000
Ending Balance (in shares) at Dec. 31, 2023                                 122       56             73,413,248 9